促进创新和获取优质、安全、有效和可负担的儿童药物决议:第69届世界卫生大会的中国办法

Promoting innovation and access to quality, safe, efficacious and affordable medicines for children: a China approach on the 69^(th) World Health Assembly

本文目的是为帮助正确理解第69届世界卫生大会"促进创新和获取优质、安全、有效和可负担的儿童药物"决议内容、制定政策和推进工作提供借鉴和参考。本文描述性地介绍决议提出背景和通过过程,解读决议内容。"促进创新和获取优质、安全、有效和可负担的儿童药物"决议获世界卫生大会通过,代表了中国在促进儿童这一最脆弱人群的基本医疗服务的国际话语权;彰显了中国的大国责任和风范;既是对中国新医改工作的有利促进和对千年目标实现的有效推进,也是中国对全球儿童健康事业的巨大贡献。

This study is to provide reference for the proper understanding of the content of ＂Promoting innovation and access to quality, safe, efficacious, and affordable medicines for children＂ resolution of 69th World Health Assembly （WHA）, and facilitate the policy making and implication of the Resolution. Through descriptive analysis, the author introduce the proposal background and approving process of the resolution, and interpret the resolution content. The approval of ＂Promoting innovation and access to quality, safe, efficacious, and affordable medicines for children＂ at WHA represents China＇s international discourse right on improving the basic medical service among children, the most vulnerable population; highlights China＇s responsibility and magnitude of a great nation. It is an effective promotion for China＇s new medical reform and the implication of the Millennium Development Goals （MDGs）, as well as a great contribution to the global health of children from China.